Disclaimer: This blog site is intended solely for sharing of information. Comments are warmly welcome, but I make no warranties regarding the quality, content, completeness, suitability, adequacy, sequence, or accuracy of the information.
Thursday, July 01, 2010
Changes in Terminology for Childhood Overweight and Obesity
Friday, June 11, 2010
Statistic software, books etc. websites
This website listed here comprise a powerful, conveniently-accessible,
multi-platform statistical software package. There are also links to
online statistics books, tutorials, downloadable software, and related
resources.
Russ Lenth's power and sample-size page
A nice website for power and sample size calculation.
http://www.stat.uiowa.edu/~rlenth/Power/#Download_to_run_locally
Wednesday, June 09, 2010
JAMA -- Beyond Hemoglobin A1c--Need for Additional Markers of Risk for Diabetic Microvascular Complications, June 9, 2010, Hirsch and Brownlee 303 (22): 2291
Microvascular Complications
Monday, June 07, 2010
Recent population changes in A1c and insulin among adults with preserved glucose homeostasis
glucose homeostasis
Attached please find our distribution paper published on Diabetologia
last week (http://www.springerlink.com/content/c5137gn6gh426115/). The
homeostasis concept at a individual level is not new, but this is a new
insight (thanks Henry teaching me this word in English) from a
population perspective. To me, this is an most important study/a
milestone of my diabetic study career so far; it changes my ways of
thinking and ordering all pieces of puzzle of diabetes significantly.
I enjoy the process of this study and very appreciate all the
contributions from the authors, Yiling
Monday, May 17, 2010
Medical News: CODHy: Debate Rages on HbA1c for Diabetes Diagnosis - in Meeting Coverage, CODHy from MedPage Today
Monday, May 10, 2010
Quotes
“To accomplish great things, we must not only act, but also dream; not only plan, but also believe.” ~ Anatole
“Only as high as I reach can I grow, only as far as I seek can I go, only as deep as I look can I see, only as much as I dream can I be.” ~ Karen Ravn
“Be who you are and say what you feel because those who mind don't matter and those who matter don't mind.” ~ Dr. Seuss
“Success is not final, failure is not fatal: it is the courage to continue that counts.” ~ Winston Churchill
“If your actions inspire others to dream more, learn more, do more and become more, you are a leader.” ~ John Quincy Adams
“Being deeply loved by someone gives you strength, while loving someone deeply gives you courage.” ~ Lao Tzu
Tuesday, April 13, 2010
Word and Phrase search in PDF Files
http://www.techsupportalert.com/content/word-and-phrase-search-pdf-files
.htm
Wednesday, April 07, 2010
Don't Be Loopy: Re-Sampling and Simulation the SASR Way
Way
Monday, April 05, 2010
A French view on obesity as a social construction, with mention of CDC.
A French view on obesity as a social construction, with mention of CDC.
Wednesday, March 24, 2010
If you've read many http://howstuffworks.com/ articles, you've seen a lot of terminology thrown around -- words such as mass, force, torque, work, power and energy. What do the-se words really mean, and are they interchangeable? Go to http://howstuffworks.com/ and find the answer.
_From Bob
It is well recognized in the methodological literature that dichotomization of continuous variables introduces major problems in the analysis and interpretation of models derived in a data-dependent fashion. Nevertheless, dichotomization of continuous variables is widespread in clinical research. Problems include loss of information, reduction in power, uncertainty in defining the cutpoint, arriving at a biologically implausible step function as the estimate of a dose–response function, and the impossibility of detecting a non-monotonic dose–response relation. Uncertainty in how to select a ‘sensible’ cutpoint to group a continuous variable into two classes has led researchers to use either the median or an ‘optimal’ cutpoint. The latter approach gives a highly inflated type 1 error probability, together with biased parameter estimates and variances that are too small [9, 11]. Although some remedies for these diffculties have been developed [9, 21–23], none of the authors of these papers actually recommends the use of ‘optimal’ cutpoints with their proposed corrections. In general, the situation seems hardly to have improved since the advice in 1993 of Maxwell and Delaney [1] to avoid dichotomization, quoted at the beginning of this paper.
Thursday, March 11, 2010
Friday, March 05, 2010
In memory of Dr. John Denis McGarry
Dr. Denis McGarry was a great teacher and sage. His lecture affects my way of thinking on diabetes. Unforgettable.
Thursday, March 04, 2010
K M Venkat Narayan: A case of well-intentioned public health reductionism?
reductionism?
Very good comments.
Tuesday, February 23, 2010
Monday, February 22, 2010
FDA internal reports unhappy about rosiglitazone (Avandia)
Research Ties Diabetes Drug to Heart Woes
http://www.nytimes.com/2010/02/20/health/policy/20avandia.html
Does anyone know why Avandia increases the risk of CHD? Is because of efficiently lowing the glucose level (too low)? Or any other side-effects.
Wednesday, February 03, 2010
A Lasting Gift to Medicine That Wasn't Really a Gift
A Lasting Gift to Medicine That Wasn’t Really a Gift
http://www.nytimes.com/2010/02/02/health/02seco.html?th&emc=th
A cell line called HeLa (for Henrietta Lacks) was born. Those immortal cells soon became the workhorse of laboratories everywhere. HeLa cells were used to develop the first polio vaccine, they were launched into space for experiments in zero gravity and they helped produce drugs for numerous diseases, including Parkinson’s, leukemia and the flu. By now, literally tons of them have been produced.
Dr. Gey did not make money from the cells, but they were commercialized. Now they are bought and sold every day the world over, and they have generated millions in profits.
Ukrainian registry of type 2 dm shows U-shaped relation of BMI to mortality
(Heart 2009;95:454-460. doi:10.1136/hrt.2008.150524)
Not too surprising, a common sense is that extreme, fundamental, or radical ends are not good. But one of the interesting figures (finding) is even obese population (≥45) had lower risk of death than low BMI population (<20 for all-cause death, and <21 for CVD death).